Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 41 of 498 for:    LENALIDOMIDE AND every 28 days

Induction Therapy for Multiple Myeloma With Carfilzomib, Lenalidomide,Dexamethasone,Panobinostat

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02802163
Recruitment Status : Withdrawn (study drug unavailable)
First Posted : June 16, 2016
Last Update Posted : April 25, 2017
Sponsor:
Collaborators:
Novartis
Amgen
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : September 2020
Estimated Study Completion Date : December 2020